What question did this study set out to answer?

To explore the role of NOX1 in obesity-related hypertension and its potential as a therapeutic target.

January 9, 2026AntioxidantsOpen Access

NADPH Oxidase 1 Mediates Endothelial Dysfunction and Hypertension in a Murine Model of Obesity

Q: What does this research mean for the field?

NOX1 deletion or inhibition with GKT771 improves endothelial function and ameliorates hypertension in obese db/db mice without altering metabolic factors. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.CHALLENGES_CONSENSUS.

View Full Paper

Ask AI

Bookmark

Key result

NOX1 deletion or inhibition with GKT771 improved endothelial function and ameliorated hypertension in obese db/db mice without altering metabolic factors.

Authors

CPCaleb A. Padgett JBJoshua T. Butcher SLSebastian Larion

Discussion

Member takes

Overview

Investigating NADPH oxidase 1's role in hypertension in a murine obesity model, highlighting its therapeutic potential.

Key Points

To explore the role of NOX1 in obesity-related hypertension and its potential as a therapeutic target.
Utilized a murine obesity model with db/db mice
Examined effects of NOX1 deletion on hypertension
Assessed renal sodium handling alongside NOX1 deletion
Evaluated the therapeutic effects of NOX1 inhibitor GKT771 on endothelial function
NOX1 deletion reduced hypertension in obese mice
NOX1 deletion improved renal sodium handling without upregulating other NOX isoforms
Treatment with GKT771 restored endothelial function in obese mice to levels seen in lean controls

Cite This Study

Padgett et al. (2026) studied this question. NOX1 deletion or inhibition with GKT771 improved endothelial function and ameliorated hypertension in obese db/db mice without altering metabolic factors.

synapsesocial.com/papers/69612fd630ef6c21f6853d71 https://doi.org/10.3390/antiox15010060

View Full Paper

Ask AI

Bookmark

January 9, 2026AntioxidantsOpen Access

NADPH Oxidase 1 Mediates Endothelial Dysfunction and Hypertension in a Murine Model of Obesity

View Full Paper

Ask AI

Bookmark

Key result

NOX1 deletion or inhibition with GKT771 improved endothelial function and ameliorated hypertension in obese db/db mice without altering metabolic factors.

Authors

CPCaleb A. Padgett JBJoshua T. Butcher SLSebastian Larion

Discussion

Member takes

Overview

Investigating NADPH oxidase 1's role in hypertension in a murine obesity model, highlighting its therapeutic potential.

Key Points

To explore the role of NOX1 in obesity-related hypertension and its potential as a therapeutic target.
Utilized a murine obesity model with db/db mice
Examined effects of NOX1 deletion on hypertension
Assessed renal sodium handling alongside NOX1 deletion
Evaluated the therapeutic effects of NOX1 inhibitor GKT771 on endothelial function
NOX1 deletion reduced hypertension in obese mice
NOX1 deletion improved renal sodium handling without upregulating other NOX isoforms
Treatment with GKT771 restored endothelial function in obese mice to levels seen in lean controls

Cite This Study

Padgett et al. (2026) studied this question. NOX1 deletion or inhibition with GKT771 improved endothelial function and ameliorated hypertension in obese db/db mice without altering metabolic factors.

synapsesocial.com/papers/69612fd630ef6c21f6853d71 https://doi.org/10.3390/antiox15010060

View Full Paper

Ask AI

Bookmark